Hits
Hits
Live

Mitochondria, potential new therapeutic targets in pancreatic cancer -

High Throughput Screening

High Throughput Screening

The platform gives access to a state-of-the-art automated platform hosting a very small volume acoustic dispenser (echo550), an in line automated centrifuge, an automated plate sealer, a multimodal plate reader (fluorescence, absorbance, luminescence). The platform also hosts a versatile dispensing robot for larger volumes manipulation. This series of pieces of equipment allow to perform fast and robust screening campaigns (thousands of compounds in 1536 well plates).

This unique high technology facility provides all the necessary tools to overcome the challenges of early drug discovery stages in oncology.

Available Technologies:

Fluorescence
TR-FRET (HTRF)
Fluorescence Polarisation
Thermal Shift Assay (TSA/DSF)
Nanobret (Promega)
Cytotoxicité 3D
Isothermal Titration Calorimetry

Equipements list :

Microplate Reader (Fluo, Abs, Lum)
Robotic Arm platform
Acoustic dispenser (Echo550)
RT-PCR 384w for TSA
FPLC (Akta Pure)
Microcalorimeter (ITC200)
Incubatos (Cell culture/Xray)

Molecular modelling for drug-design

Molecular modelling for drug-design

This unique platform integrates in a single entity the High Throughput Screening expertise (HTS) and the cheminformatics and molecular modelling know-how brought by Philippe Roche from the INT-3D platform (now part of HiTS). We propose a large variety of custom services from chemical library management to post screening analysis with focused subset generations to quickly and efficiently drive the projects to SAR by catalog. We are also able to carry the hit to lead phases once the hits are validated.

Available Technologies:

Homology Modelling
Molecular Dynamics
Virtual Screening
SAR
Ht-to-Lead Optimization
Growing Optimization (DOTS)
Covalent Inhititors (CovaDOTS - CovaLink - CovaGrow CovaProbe)
Fragment Libraries
Focused Libraries
Databases/Servers (2P2IDB)

Software:

Modeller
VMD
PyMOL
Charmm
Amber
NAMD
ChemAxon
SeeSAR
LigandScout
RDKit
MOE
PLANTS
DataWarrior

The HiTS/IPCdd platform brings together a set of skills and technologies to accelerate the discovery of bioactive molecules either using experimental (in vitro or cellular) screening or molecular modelling for drug design approaches. Our goals are to identify, understand, validate and screen key signaling pathways of tumor development (enzymes, protein/protein interaction surfaces …) with a specific target being facilitate the transfer of the identified therapeutics / pharmacological targets to preclinical and clinical development in oncology.

High Throughput Screening

The platform gives access to a state-of-the-art automated platform hosting a very small volume acoustic dispenser (echo550), an in line automated centrifuge, an automated plate sealer, a multimodal plate reader (fluorescence, absorbance, luminescence). The platform also hosts a versatile dispensing robot for larger volumes manipulation. This series of pieces of equipment allow to perform fast and robust screening campaigns (thousands of compounds in 1536 well plates). This unique high technology facility provides all the necessary tools to overcome the challenges of early drug discovery stages in oncology.

Molecular modelling for drug-design

This unique platform integrates in a single entity the High Throughput Screening expertise (HTS) and the cheminformatics and molecular modelling know-how brought by Philippe Roche from the INT-3D platform (now part of HiTS). We propose a large variety of custom services from chemical library management to post screening analysis with focused subset generations to quickly and efficiently drive the projects to SAR by catalog. We are also able to carry the hit to lead phases once the hits are validated.